California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cutsnews2023-03-24T15:25:37+00:00March 24th, 2023|The New York Times|
More Doctors Can Now Prescribe Buprenorphine to Opioid Users. Will It Help?news2023-03-03T08:00:11+00:00March 3rd, 2023|The New York Times|
Bernie Sanders Has a New Role. It Could Be His Final Act in Washington.news2023-02-12T16:25:40+00:00February 12th, 2023|The New York Times|
California Sues Companies Over Insulin Prices, Joining Other Statesnews2023-01-18T17:16:35+00:00January 18th, 2023|The New York Times|
Medicare Begins to Rein In Drug Costs for Older Americansnews2023-01-14T16:52:43+00:00January 14th, 2023|The New York Times|
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?news2022-12-16T10:00:26+00:00December 16th, 2022|The New York Times|
A Surge of Overseas Abortion Pills Blunted the Effects of State Abortion Bansnews2022-11-01T21:22:02+00:00November 1st, 2022|The New York Times|
As Midterms Near, Biden Warns Republicans Seek to Dismantle Democratic Legislationnews2022-10-22T03:55:01+00:00October 22nd, 2022|The New York Times|
FDA’s Drug Industry Fees Fuel Concerns Over Influencenews2022-09-15T09:00:26+00:00September 15th, 2022|The New York Times|
Medicare Recipients Could Find Drug Cost Relief in Health Billnews2022-08-10T07:00:11+00:00August 10th, 2022|The New York Times|
